FDA DTC Study Could Impact Advertising Targeting Adolescents

The FDA plans to study how adolescents interpret direct-to-consumer (DTC) advertisements, research that could impact how drugmakers develop postmarket advertisements and how the agency regulates them. The FDA hopes to see how adolescents process the benefit-risk profile of a prescription drug, which could impact how that profile is communicated in marketing.
Washington Drug Letter